Sensitization of TRAIL-resistant LNCaP cells by resveratrol (3, 4', 5 tri-hydroxystilbene): molecular mechanisms and therapeutic potential

Explore this paper's citation graph

Summary

Resveratrol either alone or in combination with TRAIL or Smac can be used for the prevention and/or treatment of human prostate cancer.

Type
article
Published
2007-08-24
Cited by
96
References
71
Access
Open access

Keywords

Sensitization, Resveratrol, LNCaP, Medicine, Internal medicine

References

Cited by

Related papers